{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:21:59Z","timestamp":1790914919350,"version":"4.1.0"},"reference-count":101,"publisher":"F1000 Research Ltd","license":[{"start":{"date-parts":[[2020,2,10]],"date-time":"2020-02-10T00:00:00Z","timestamp":1581292800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["1U01AA026978-01"],"award-info":[{"award-number":["1U01AA026978-01"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["1U01AA026972-01"],"award-info":[{"award-number":["1U01AA026972-01"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["1U01AA026264-01"],"award-info":[{"award-number":["1U01AA026264-01"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["f1000research.com"],"crossmark-restriction":false},"short-container-title":["F1000Res"],"abstract":"<ns4:p>Alcoholic hepatitis is the severest clinical presentation of alcoholic liver disease. Lacking an effective pharmacologic treatment, alcoholic hepatitis is associated with a poor prognosis and its recovery relies mostly on abstinence. With alcohol use disorder being universally on the rise, the impact of alcoholic hepatitis on society and health-care costs is expected to increase significantly. Prognostic factors and liver biopsy can help with timely diagnosis, to determine eligibility and response to corticosteroids, and for prognostication and transplant referral. Although recent discoveries in the pathophysiology of alcoholic hepatitis are encouraging and could pave the way for novel treatment modalities, a multidisciplinary approach considering timely identification and treatment of liver-related complications, infectious and metabolic disease, malnutrition, and addiction counseling should be emphasized. Apart from proper selection of candidates, transplant programs should provide adequate post-transplant addiction support in order to make of early liver transplantation for alcoholic hepatitis the ultimate sobering experience in the next decade.<\/ns4:p>","DOI":"10.12688\/f1000research.20394.1","type":"journal-article","created":{"date-parts":[[2020,2,10]],"date-time":"2020-02-10T05:00:13Z","timestamp":1581310813000},"page":"97","update-policy":"https:\/\/doi.org\/10.12688\/f1000research.crossmark-policy","source":"Crossref","is-referenced-by-count":22,"title":["Recent advances in alcoholic hepatitis"],"prefix":"10.12688","volume":"9","author":[{"given":"Vikrant","family":"Rachakonda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramon","family":"Bataller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5377-9295","authenticated-orcid":false,"given":"Andres","family":"Duarte-Rojo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2560","published-online":{"date-parts":[[2020,2,10]]},"reference":[{"key":"ref-1","doi-asserted-by":"publisher","first-page":"555-64","DOI":"10.1016\/j.cgh.2013.06.013","article-title":"Alcoholic hepatitis: current challenges and future directions.","volume":"12","author":"A Singal","year":"2014","journal-title":"Clin Gastroenterol Hepatol."},{"key":"ref-2","doi-asserted-by":"publisher","first-page":"785-90","DOI":"10.1053\/j.gastro.2016.02.042","article-title":"Standard Definitions and Common Data Elements for Clinical Trials in Patients With Alcoholic Hepatitis: Recommendation From the NIAAA Alcoholic Hepatitis Consortia.","volume":"150","author":"D Crabb","year":"2016","journal-title":"Gastroenterology."},{"key":"ref-3","doi-asserted-by":"publisher","first-page":"1713-9","DOI":"10.1111\/acer.12152","article-title":"Tax policy, adult binge drinking, and youth alcohol consumption in the United States.","volume":"37","author":"Z Xuan","year":"2013","journal-title":"Alcohol Clin Exp Res."},{"key":"ref-4","doi-asserted-by":"publisher","first-page":"55-61","DOI":"10.1111\/add.12358","article-title":"Legalization of Sunday alcohol sales and alcohol consumption in the United States.","volume":"109","author":"B Y\u00f6r\u00fck","year":"2014","journal-title":"Addiction."},{"key":"ref-5","doi-asserted-by":"publisher","first-page":"191-201","DOI":"10.1080\/08897077.2011.601250","article-title":"Alcohol brand preferences of underage youth: results from a pilot survey among a national sample.","volume":"32","author":"M Siegel","year":"2011","journal-title":"Subst Abus."},{"key":"ref-6","doi-asserted-by":"publisher","first-page":"419-26","DOI":"10.1016\/j.amepre.2010.12.011","article-title":"Alcoholic beverage preferences and associated drinking patterns and risk behaviors among high school youth.","volume":"40","author":"M Siegel","year":"2011","journal-title":"Am J Prev Med."},{"key":"ref-7","doi-asserted-by":"publisher","first-page":"343-8","DOI":"10.1093\/alcalc\/agt002","article-title":"Alcohol use during the great recession of 2008\u20132009.","volume":"48","author":"J Bor","year":"2013","journal-title":"Alcohol Alcohol."},{"key":"ref-8","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k2817","article-title":"Mortality due to cirrhosis and liver cancer in the United States, 1999\u20132016: observational study.","volume":"362","author":"E Tapper","year":"2018","journal-title":"BMJ."},{"key":"ref-9","doi-asserted-by":"publisher","first-page":"760-4","DOI":"10.1016\/j.jhep.2010.07.016","article-title":"Incidence and mortality of alcoholic hepatitis in Denmark 1999\u20132008: a nationwide population based cohort study.","volume":"54","author":"T Sandahl","year":"2011","journal-title":"J Hepatol."},{"key":"ref-10","doi-asserted-by":"crossref","first-page":"506-11","DOI":"10.1097\/MCG.0000000000000161","article-title":"Trends in Alcoholic Hepatitis-related Hospitalizations, Financial Burden, and Mortality in the United States.","volume":"49","author":"R Jinjuvadia","year":"2015","journal-title":"J Clin Gastroenterol."},{"key":"ref-11","doi-asserted-by":"publisher","first-page":"1460-9","DOI":"10.1007\/s10620-019-5471-7","article-title":"Charges for Alcoholic Cirrhosis Exceed All Other Etiologies of Cirrhosis Combined: A National and State Inpatient Survey Analysis.","volume":"64","author":"A Barritt","year":"2019","journal-title":"Dig Dis Sci."},{"key":"ref-12","first-page":"237-50","article-title":"The Role of Innate Immunity in Alcoholic Liver Disease.","volume":"37","author":"L Nagy","year":"2015","journal-title":"Alcohol Res."},{"key":"ref-13","doi-asserted-by":"publisher","first-page":"155-201","DOI":"10.1016\/b978-0-12-405211-6.00006-1","article-title":"Toll-like receptors in liver disease.","volume":"59","author":"J Petrasek","year":"2013","journal-title":"Adv Clin Chem."},{"key":"ref-14","doi-asserted-by":"publisher","first-page":"1572-85","DOI":"10.1053\/j.gastro.2011.09.002","article-title":"Alcoholic liver disease: pathogenesis and new therapeutic targets.","volume":"141","author":"B Gao","year":"2011","journal-title":"Gastroenterology."},{"key":"ref-15","doi-asserted-by":"publisher","first-page":"9817-26","DOI":"10.1074\/jbc.M111.333534","article-title":"MicroRNA-217 promotes ethanol-induced fat accumulation in hepatocytes by down-regulating SIRT1.","volume":"287","author":"H Yin","year":"2012","journal-title":"J Biol Chem."},{"key":"ref-16","doi-asserted-by":"publisher","first-page":"E4485-E4493","DOI":"10.1073\/pnas.1415174111","article-title":"Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity.","volume":"111","author":"S Leclercq","year":"2014","journal-title":"Proc Natl Acad Sci U S A."},{"key":"ref-17","doi-asserted-by":"publisher","first-page":"742-7","DOI":"10.1016\/S0168-8278(00)80242-1","article-title":"Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease.","volume":"32","author":"A Parlesak","year":"2000","journal-title":"J Hepatol."},{"key":"ref-18","doi-asserted-by":"publisher","first-page":"1639-50","DOI":"10.1053\/j.gastro.2009.01.056","article-title":"Hepatic expression of CXC chemokines predicts portal hypertension and survival in patients with alcoholic hepatitis.","volume":"136","author":"M Dominguez","year":"2009","journal-title":"Gastroenterology."},{"key":"ref-19","doi-asserted-by":"publisher","first-page":"1949-60","DOI":"10.1136\/gutjnl-2014-308410","article-title":"Progenitor cell expansion and impaired hepatocyte regeneration in explanted livers from alcoholic hepatitis.","volume":"64","author":"L Dubuquoy","year":"2015","journal-title":"Gut."},{"key":"ref-20","doi-asserted-by":"publisher","first-page":"609-21","DOI":"10.1016\/j.jhep.2015.04.003","article-title":"Hepatic cell proliferation plays a pivotal role in the prognosis of alcoholic hepatitis.","volume":"63","author":"N Lanthier","year":"2015","journal-title":"J Hepatol."},{"key":"ref-21","doi-asserted-by":"publisher","first-page":"1931-41","DOI":"10.1002\/hep.25614","article-title":"Liver progenitor cell markers correlate with liver damage and predict short-term mortality in patients with alcoholic hepatitis.","volume":"55","author":"P Sancho-Bru","year":"2012","journal-title":"Hepatology."},{"key":"ref-22","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.1038\/s41467-019-11004-3","article-title":"Defective HNF4alpha-dependent gene expression as a driver of hepatocellular failure in alcoholic hepatitis.","volume":"10","author":"J Argemi","year":"2019","journal-title":"Nat Commun."},{"key":"ref-23","doi-asserted-by":"publisher","first-page":"1096-106","DOI":"10.1056\/NEJMoa1712191","article-title":"A Protein-Truncating HSD17B13 Variant and Protection from Chronic Liver Disease.","volume":"378","author":"N Abul-Husn","year":"2018","journal-title":"N Engl J Med."},{"key":"ref-24","doi-asserted-by":"publisher","first-page":"21-3","DOI":"10.1038\/ng.488","article-title":"Variant in PNPLA3 is associated with alcoholic liver disease.","volume":"42","author":"C Tian","year":"2010","journal-title":"Nat Genet."},{"key":"ref-25","doi-asserted-by":"publisher","first-page":"1443-8","DOI":"10.1038\/ng.3417","article-title":"A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis.","volume":"47","author":"S Buch","year":"2015","journal-title":"Nat Genet."},{"key":"ref-26","doi-asserted-by":"publisher","first-page":"528-32","DOI":"10.1016\/s0014-2565(05)72632-1","article-title":"[Genetic susceptibility to the development of acute alcoholic hepatitis: role of genetic mutations in dehydrogenase alcohol, aldehyde dehydrogenase and cytochrome P450 2E1].","volume":"205","author":"A Segado Soriano","year":"2005","journal-title":"Rev Clin Esp."},{"key":"ref-27","doi-asserted-by":"publisher","first-page":"965-75","DOI":"10.1053\/j.gastro.2017.10.048","article-title":"Combination of Gene Expression Signature and Model for End-Stage Liver Disease Score Predicts Survival of Patients With Severe Alcoholic Hepatitis.","volume":"154","author":"E Tr\u00e9po","year":"2018","journal-title":"Gastroenterology."},{"key":"ref-28","doi-asserted-by":"publisher","first-page":"235-46","DOI":"10.1038\/s41575-018-0099-1","article-title":"Alcohol, liver disease and the gut microbiota.","volume":"16","author":"J Bajaj","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"ref-29","doi-asserted-by":"publisher","first-page":"830-9","DOI":"10.1136\/gutjnl-2015-310585","article-title":"Intestinal microbiota contributes to individual susceptibility to alcoholic liver disease.","volume":"65","author":"M Llopis","year":"2016","journal-title":"Gut."},{"key":"ref-30","doi-asserted-by":"publisher","first-page":"e0174544","DOI":"10.1371\/journal.pone.0174544","article-title":"Alcohol-related changes in the intestinal microbiome influence neutrophil infiltration, inflammation and steatosis in early alcoholic hepatitis in mice.","volume":"12","author":"P Lowe","year":"2017","journal-title":"PLoS One."},{"key":"ref-31","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30832","article-title":"Intestinal Fungal Dysbiosis and Systemic Immune Response to Fungi in Patients With Alcoholic Hepatitis.","author":"S Lang","year":"2019","journal-title":"Hepatology."},{"key":"ref-32","doi-asserted-by":"publisher","DOI":"10.3390\/medsci6030079","article-title":"Gut\u2013Liver Axis: How Do Gut Bacteria Influence the Liver?","volume":"6","author":"P Konturek","year":"2018","journal-title":"Med Sci (Basel)."},{"key":"ref-33","doi-asserted-by":"publisher","first-page":"S816","DOI":"10.1016\/S0168-8278(18)31905-6","article-title":"Use of rifaximin in alcoholic hepatitis: Pilot study.","volume":"68","author":"C Jimenez","year":"2018","journal-title":"J Hepatol."},{"key":"ref-34","doi-asserted-by":"publisher","first-page":"600-2","DOI":"10.1016\/j.cgh.2016.10.029","article-title":"Healthy Donor Fecal Microbiota Transplantation in Steroid-Ineligible Severe Alcoholic Hepatitis: A Pilot Study.","volume":"15","author":"C Philips","year":"2017","journal-title":"Clin Gastroenterol Hepatol."},{"key":"ref-35","doi-asserted-by":"publisher","first-page":"399-420","DOI":"10.1016\/j.jhep.2012.04.004","article-title":"EASL clinical practical guidelines: management of alcoholic liver disease.","volume":"57","year":"2012","journal-title":"J Hepatol."},{"key":"ref-36","doi-asserted-by":"publisher","first-page":"2758-69","DOI":"10.1056\/NEJMra0805786","article-title":"Alcoholic hepatitis.","volume":"360","author":"M Lucey","year":"2009","journal-title":"N Engl J Med."},{"key":"ref-37","doi-asserted-by":"publisher","first-page":"1231-1239.e6","DOI":"10.1053\/j.gastro.2014.01.018","article-title":"A histologic scoring system for prognosis of patients with alcoholic hepatitis.","volume":"146","author":"J Altamirano","year":"2014","journal-title":"Gastroenterology."},{"key":"ref-38","doi-asserted-by":"publisher","first-page":"193-9","DOI":"10.1016\/0016-5085(78)90401-8","article-title":"Corticosteroid therapy of alcoholic hepatitis.","volume":"75","author":"W Maddrey","year":"1978","journal-title":"Gastroenterology."},{"key":"ref-39","doi-asserted-by":"publisher","first-page":"65-71.e3","DOI":"10.1016\/j.cgh.2011.09.011","article-title":"Acute kidney injury is an early predictor of mortality for patients with alcoholic hepatitis.","volume":"10","author":"J Altamirano","year":"2012","journal-title":"Clin Gastroenterol Hepatol."},{"key":"ref-40","doi-asserted-by":"publisher","first-page":"353-8","DOI":"10.1002\/hep.20503","article-title":"MELD accurately predicts mortality in patients with alcoholic hepatitis.","volume":"41","author":"W Dunn","year":"2005","journal-title":"Hepatology."},{"key":"ref-41","doi-asserted-by":"publisher","first-page":"2747-56","DOI":"10.1111\/j.1572-0241.2008.02104.x","article-title":"A new scoring system for prognostic stratification of patients with alcoholic hepatitis.","volume":"103","author":"M Dominguez","year":"2008","journal-title":"Am J Gastroenterol."},{"key":"ref-42","doi-asserted-by":"publisher","first-page":"1174-9","DOI":"10.1136\/gut.2004.050781","article-title":"Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score.","volume":"54","author":"E Forrest","year":"2005","journal-title":"Gut."},{"key":"ref-43","doi-asserted-by":"publisher","first-page":"1743-6","DOI":"10.1136\/gut.2006.099226","article-title":"The Glasgow alcoholic hepatitis score identifies patients who may benefit from corticosteroids.","volume":"56","author":"E Forrest","year":"2007","journal-title":"Gut."},{"key":"ref-44","doi-asserted-by":"publisher","first-page":"1348-54","DOI":"10.1002\/hep.21607","article-title":"The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids.","volume":"45","author":"A Louvet","year":"2007","journal-title":"Hepatology."},{"key":"ref-45","doi-asserted-by":"publisher","first-page":"306-15","DOI":"10.1038\/ajg.2016.539","article-title":"A Day-4 Lille Model Predicts Response to Corticosteroids and Mortality in Severe Alcoholic Hepatitis.","volume":"112","author":"M Garcia-Saenz-de-Sicilia","year":"2017","journal-title":"Am J Gastroenterol."},{"key":"ref-46","doi-asserted-by":"publisher","first-page":"398-406.e8","DOI":"10.1053\/j.gastro.2015.04.044","article-title":"Combining Data From Liver Disease Scoring Systems Better Predicts Outcomes of Patients With Alcoholic Hepatitis.","volume":"149","author":"A Louvet","year":"2015","journal-title":"Gastroenterology."},{"key":"ref-47","doi-asserted-by":"publisher","first-page":"511-8","DOI":"10.1016\/j.jhep.2017.11.017","article-title":"Application of prognostic scores in the STOPAH trial: Discriminant function is no longer the optimal scoring system in alcoholic hepatitis.","volume":"68","author":"E Forrest","year":"2018","journal-title":"J Hepatol."},{"key":"ref-48","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s12967-015-0623-9","article-title":"Increased number of circulating exosomes and their microRNA cargos are potential novel biomarkers in alcoholic hepatitis.","volume":"13","author":"F Momen-Heravi","year":"2015","journal-title":"J Transl Med."},{"key":"ref-49","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1002\/hep.26111","article-title":"Reply: To PMID 22684891.","volume":"57","author":"G Szabo","year":"2013","journal-title":"Hepatology."},{"key":"ref-50","doi-asserted-by":"publisher","first-page":"2712-21","DOI":"10.1111\/acer.12558","article-title":"Stratification of risk of death in severe acute alcoholic hepatitis using a panel of adipokines and cytokines.","volume":"38","author":"V Rachakonda","year":"2014","journal-title":"Alcohol Clin Exp Res."},{"key":"ref-51","doi-asserted-by":"publisher","first-page":"301-12","DOI":"10.3727\/105221617X15016197658871","article-title":"Cell Death and Prognosis of Mortality in Alcoholic Hepatitis Patients Using Plasma Keratin-18.","volume":"17","author":"B Woolbright","year":"2017","journal-title":"Gene Expr."},{"key":"ref-52","doi-asserted-by":"publisher","first-page":"555-63","DOI":"10.1002\/hep.29080","article-title":"A prospective study of the utility of plasma biomarkers to diagnose alcoholic hepatitis.","volume":"66","author":"J Bissonnette","year":"2017","journal-title":"Hepatology."},{"key":"ref-53","doi-asserted-by":"publisher","first-page":"G115-G122","DOI":"10.1152\/ajpgi.00209.2018","article-title":"Urinary acrolein metabolite levels in severe acute alcoholic hepatitis patients.","volume":"316","author":"V Vatsalya","year":"2019","journal-title":"Am J Physiol Gastrointest Liver Physiol."},{"key":"ref-54","doi-asserted-by":"publisher","first-page":"442-53","DOI":"10.1111\/apt.15335","article-title":"Baseline neutrophil-to-lymphocyte ratio predicts response to corticosteroids and is associated with infection and renal dysfunction in alcoholic hepatitis.","volume":"50","author":"E Forrest","year":"2019","journal-title":"Aliment Pharmacol Ther."},{"key":"ref-55","doi-asserted-by":"publisher","first-page":"1350-5","DOI":"10.1056\/NEJM197106172842404","article-title":"Corticosteroid therapy in severe alcoholic hepatitis. A double-blind drug trial.","volume":"284","author":"H Porter","year":"1971","journal-title":"N Engl J Med."},{"key":"ref-56","doi-asserted-by":"publisher","first-page":"1637-48","DOI":"10.1053\/gast.2000.20189","article-title":"Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial.","volume":"119","author":"E Akriviadis","year":"2000","journal-title":"Gastroenterology."},{"key":"ref-57","doi-asserted-by":"publisher","first-page":"1619-28","DOI":"10.1056\/NEJMoa1412278","article-title":"Prednisolone or pentoxifylline for alcoholic hepatitis.","volume":"372","author":"M Thursz","year":"2015","journal-title":"N Engl J Med."},{"key":"ref-58","doi-asserted-by":"publisher","first-page":"958-970.e12","DOI":"10.1053\/j.gastro.2015.06.006","article-title":"Comparative Effectiveness of Pharmacological Interventions for Severe Alcoholic Hepatitis: A Systematic Review and Network Meta-analysis.","volume":"149","author":"S Singh","year":"2015","journal-title":"Gastroenterology."},{"key":"ref-59","doi-asserted-by":"publisher","first-page":"458-468.e8","DOI":"10.1053\/j.gastro.2018.05.011","article-title":"Corticosteroids Reduce Risk of Death Within 28 Days for Patients With Severe Alcoholic Hepatitis, Compared With Pentoxifylline or Placebo-a Meta-analysis of Individual Data From Controlled Trials.","volume":"155","author":"A Louvet","year":"2018","journal-title":"Gastroenterology."},{"key":"ref-60","doi-asserted-by":"publisher","first-page":"505-512.e1","DOI":"10.1053\/j.gastro.2011.11.027","article-title":"Granulocyte colony-stimulating factor mobilizes CD34+ cells and improves survival of patients with acute-on-chronic liver failure.","volume":"142","author":"V Garg","year":"2012","journal-title":"Gastroenterology."},{"key":"ref-61","doi-asserted-by":"publisher","first-page":"1362-1370.e7","DOI":"10.1053\/j.gastro.2015.02.054","article-title":"Combination of granulocyte colony-stimulating factor and erythropoietin improves outcomes of patients with decompensated cirrhosis.","volume":"148","author":"C Kedarisetty","year":"2015","journal-title":"Gastroenterology."},{"key":"ref-62","doi-asserted-by":"publisher","first-page":"1417-23","DOI":"10.1038\/ajg.2014.154","article-title":"Granulocyte colony-stimulating factor in severe alcoholic hepatitis: a randomized pilot study.","volume":"109","author":"V Singh","year":"2014","journal-title":"Am J Gastroenterol."},{"key":"ref-63","doi-asserted-by":"publisher","first-page":"221-9","DOI":"10.1002\/hep.22317","article-title":"Granulocyte-colony stimulating factor induces proliferation of hepatic progenitors in alcoholic steatohepatitis: a randomized trial.","volume":"48","author":"L Spahr","year":"2008","journal-title":"Hepatology."},{"key":"ref-64","doi-asserted-by":"publisher","first-page":"1650-1656.e2","DOI":"10.1016\/j.cgh.2018.01.040","article-title":"Efficacy of Granulocyte Colony-Stimulating Factor and N-Acetylcysteine Therapies in Patients With Severe Alcoholic Hepatitis.","volume":"16","author":"V Singh","year":"2018","journal-title":"Clin Gastroenterol Hepatol."},{"key":"ref-65","doi-asserted-by":"publisher","first-page":"802-11","DOI":"10.1002\/hep.30516","article-title":"Efficacy of Granulocyte Colony-stimulating Factor in the Management of Steroid-Nonresponsive Severe Alcoholic Hepatitis: A Double-Blind Randomized Controlled Trial.","volume":"70","author":"S Shasthry","year":"2019","journal-title":"Hepatology."},{"key":"ref-66","doi-asserted-by":"publisher","first-page":"1842-53","DOI":"10.1002\/hep.29338","article-title":"Alcohol abstinence in patients surviving an episode of alcoholic hepatitis: Prediction and impact on long-term survival.","volume":"66","author":"J Altamirano","year":"2017","journal-title":"Hepatology."},{"key":"ref-67","doi-asserted-by":"publisher","first-page":"1464-73","DOI":"10.1002\/hep.29240","article-title":"Main drivers of outcome differ between short term and long term in severe alcoholic hepatitis: A prospective study.","volume":"66","author":"A Louvet","year":"2017","journal-title":"Hepatology."},{"key":"ref-68","doi-asserted-by":"publisher","first-page":"844-54","DOI":"10.1097\/01.alc.0000164374.32229.a2","article-title":"Effectiveness of the derived Alcohol Use Disorders Identification Test (AUDIT-C) in screening for alcohol use disorders and risk drinking in the US general population.","volume":"29","author":"D Dawson","year":"2005","journal-title":"Alcohol Clin Exp Res."},{"key":"ref-69","doi-asserted-by":"publisher","first-page":"384-8","DOI":"10.1016\/j.drugalcdep.2012.05.029","article-title":"Comparative performance of the AUDIT-C in screening for DSM-IV and DSM-5 alcohol use disorders.","volume":"126","author":"D Dawson","year":"2012","journal-title":"Drug Alcohol Depend."},{"key":"ref-70","doi-asserted-by":"publisher","first-page":"1910-28","DOI":"10.1001\/jama.2018.12086","article-title":"Screening and Behavioral Counseling Interventions to Reduce Unhealthy Alcohol Use in Adolescents and Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.","volume":"320","author":"E O'Connor","year":"2018","journal-title":"JAMA."},{"key":"ref-71","doi-asserted-by":"publisher","first-page":"957-60","DOI":"10.1016\/S2215-0366(18)30303-1","article-title":"Baclofen for the treatment of alcohol use disorder: The Cagliari Statement.","volume":"5","author":"R Agabio","year":"2018","journal-title":"Lancet Psychiatry."},{"key":"ref-72","doi-asserted-by":"publisher","first-page":"232-42","DOI":"10.1111\/acps.12905","article-title":"Baclofen for alcohol use disorder-a systematic meta-analysis.","volume":"138","author":"T Bschor","year":"2018","journal-title":"Acta Psychiatr Scand."},{"key":"ref-73","doi-asserted-by":"publisher","first-page":"795-806","DOI":"10.1016\/j.euroneuro.2018.03.017","article-title":"Efficacy, tolerability, and safety of low-dose and high-dose baclofen in the treatment of alcohol dependence: A systematic review and meta-analysis.","volume":"28","author":"M Pierce","year":"2018","journal-title":"Eur Neuropsychopharmacol."},{"key":"ref-74","doi-asserted-by":"publisher","first-page":"1396-406","DOI":"10.1111\/add.14191","article-title":"Baclofen: its effectiveness in reducing harmful drinking, craving, and negative mood. A meta-analysis.","volume":"113","author":"A Rose","year":"2018","journal-title":"Addiction."},{"key":"ref-75","doi-asserted-by":"publisher","first-page":"1889-900","DOI":"10.1001\/jama.2014.3628","article-title":"Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis.","volume":"311","author":"D Jonas","year":"2014","journal-title":"JAMA."},{"key":"ref-76","doi-asserted-by":"publisher","first-page":"1192-200","DOI":"10.1007\/s00535-017-1336-z","article-title":"Clinical and microbiological features of infection in alcoholic hepatitis: an international cohort study.","volume":"52","author":"R Parker","year":"2017","journal-title":"J Gastroenterol."},{"key":"ref-77","doi-asserted-by":"publisher","first-page":"831-40","DOI":"10.1002\/hep.21737","article-title":"Neutrophil dysfunction in alcoholic hepatitis superimposed on cirrhosis is reversible and predicts the outcome.","volume":"46","author":"R Mookerjee","year":"2007","journal-title":"Hepatology."},{"key":"ref-78","doi-asserted-by":"publisher","first-page":"1041-8","DOI":"10.1016\/j.jhep.2015.12.005","article-title":"Impaired intracellular signaling, myeloperoxidase release and bactericidal activity of neutrophils from patients with alcoholic cirrhosis.","volume":"64","author":"A Boussif","year":"2016","journal-title":"J Hepatol."},{"key":"ref-79","doi-asserted-by":"publisher","first-page":"1068-1077.e4","DOI":"10.1053\/j.gastro.2016.12.019","article-title":"In Patients With Severe Alcoholic Hepatitis, Prednisolone Increases Susceptibility to Infection and Infection-Related Mortality, and Is Associated With High Circulating Levels of Bacterial DNA.","volume":"152","author":"N Vergis","year":"2017","journal-title":"Gastroenterology."},{"key":"ref-80","doi-asserted-by":"publisher","first-page":"541-8","DOI":"10.1053\/j.gastro.2009.04.062","article-title":"Infection in patients with severe alcoholic hepatitis treated with steroids: early response to therapy is the key factor.","volume":"137","author":"A Louvet","year":"2009","journal-title":"Gastroenterology."},{"key":"ref-81","doi-asserted-by":"publisher","first-page":"193-7","DOI":"10.1007\/s11046-014-9740-x","article-title":"Invasive mycosis in medical intensive care unit patients with severe alcoholic hepatitis.","volume":"177","author":"T Lahmer","year":"2014","journal-title":"Mycopathologia."},{"key":"ref-82","doi-asserted-by":"publisher","first-page":"762-72","DOI":"10.1002\/hep.27779","article-title":"Systemic inflammatory response and serum lipopolysaccharide levels predict multiple organ failure and death in alcoholic hepatitis.","volume":"62","author":"J Michelena","year":"2015","journal-title":"Hepatology."},{"key":"ref-83","doi-asserted-by":"publisher","first-page":"590-6","DOI":"10.1177\/0148607185009005590","article-title":"VA Cooperative Study on Alcoholic Hepatitis. III: Changes in protein-calorie malnutrition associated with 30 days of hospitalization with and without enteral nutritional therapy.","volume":"9","author":"C Mendenhall","year":"1985","journal-title":"JPEN J Parenter Enteral Nutr."},{"key":"ref-84","doi-asserted-by":"publisher","first-page":"213-8","DOI":"10.1093\/ajcn\/43.2.213","article-title":"VA cooperative study on alcoholic hepatitis. II: Prognostic significance of protein-calorie malnutrition.","volume":"43","author":"C Mendenhall","year":"1986","journal-title":"Am J Clin Nutr."},{"key":"ref-85","doi-asserted-by":"publisher","first-page":"903-910.e8","DOI":"10.1053\/j.gastro.2015.12.038","article-title":"Intensive Enteral Nutrition Is Ineffective for Patients With Severe Alcoholic Hepatitis Treated With Corticosteroids.","volume":"150","author":"C Moreno","year":"2016","journal-title":"Gastroenterology."},{"key":"ref-86","doi-asserted-by":"publisher","first-page":"G625-G633","DOI":"10.1152\/ajpgi.00350.2009","article-title":"The role of zinc deficiency in alcohol-induced intestinal barrier dysfunction.","volume":"298","author":"W Zhong","year":"2010","journal-title":"Am J Physiol Gastrointest Liver Physiol."},{"key":"ref-87","doi-asserted-by":"publisher","first-page":"625-33","DOI":"10.1002\/lt.24750","article-title":"A multicenter study to define sarcopenia in patients with end-stage liver disease.","volume":"23","author":"E Carey","year":"2017","journal-title":"Liver Transpl."},{"key":"ref-88","doi-asserted-by":"publisher","first-page":"794-7","DOI":"10.1016\/j.transproceed.2019.01.030","article-title":"Gait Speed and Grip Strength Are Associated With Dropping Out of the Liver Transplant Waiting List.","volume":"51","author":"S Kulkarni","year":"2019","journal-title":"Transplant Proc."},{"key":"ref-89","doi-asserted-by":"publisher","first-page":"1768-75","DOI":"10.1038\/ajg.2016.336","article-title":"Frailty as Tested by Gait Speed is an Independent Risk Factor for Cirrhosis Complications that Require Hospitalization.","volume":"111","author":"M Dunn","year":"2016","journal-title":"Am J Gastroenterol."},{"key":"ref-90","doi-asserted-by":"publisher","first-page":"1675-82","DOI":"10.1053\/j.gastro.2019.01.028","article-title":"Frailty Associated With Waitlist Mortality Independent of Ascites and Hepatic Encephalopathy in a Multicenter Study.","volume":"156","author":"J Lai","year":"2019","journal-title":"Gastroenterology."},{"key":"ref-91","doi-asserted-by":"publisher","first-page":"1728-35","DOI":"10.1002\/lt.21298","article-title":"The impact of acute alcoholic hepatitis in the explanted recipient liver on outcome after liver transplantation.","volume":"13","author":"J Wells","year":"2007","journal-title":"Liver Transpl."},{"key":"ref-92","doi-asserted-by":"publisher","first-page":"358-63","DOI":"10.1093\/alcalc\/agl033","article-title":"Liver transplantation for alcoholic liver disease: a systematic review of psychosocial selection criteria.","volume":"41","author":"S McCallum","year":"2006","journal-title":"Alcohol Alcohol."},{"key":"ref-93","doi-asserted-by":"publisher","first-page":"197-205","DOI":"10.1002\/lt.20934","article-title":"Long-term survival and predictors of relapse after orthotopic liver transplantation for alcoholic liver disease.","volume":"13","author":"R Pfitzmann","year":"2007","journal-title":"Liver Transpl."},{"key":"ref-94","doi-asserted-by":"publisher","first-page":"2305-12","DOI":"10.1111\/j.1600-6143.2010.03232.x","article-title":"Trajectories of alcohol consumption following liver transplantation.","volume":"10","author":"A DiMartini","year":"2010","journal-title":"Am J Transplant."},{"key":"ref-95","doi-asserted-by":"publisher","first-page":"1183-8","DOI":"10.1001\/archinte.167.11.1183","article-title":"A simple score for predicting alcohol relapse after liver transplantation: results from 387 patients over 15 years.","volume":"167","author":"A de Gottardi","year":"2007","journal-title":"Arch Intern Med."},{"key":"ref-96","doi-asserted-by":"publisher","first-page":"1790-800","DOI":"10.1056\/NEJMoa1105703","article-title":"Early liver transplantation for severe alcoholic hepatitis.","volume":"365","author":"P Mathurin","year":"2011","journal-title":"N Engl J Med."},{"key":"ref-97","doi-asserted-by":"publisher","first-page":"841-9","DOI":"10.1111\/ajt.13586","article-title":"Early Liver Transplantation for Severe Alcoholic Hepatitis in the United States--A Single-Center Experience.","volume":"16","author":"G Im","year":"2016","journal-title":"Am J Transplant."},{"key":"ref-98","doi-asserted-by":"publisher","first-page":"20-9","DOI":"10.1097\/SLA.0000000000001831","article-title":"Three-year Results of a Pilot Program in Early Liver Transplantation for Severe Alcoholic Hepatitis.","volume":"265","author":"B Lee","year":"2017","journal-title":"Ann Surg."},{"key":"ref-99","doi-asserted-by":"publisher","first-page":"422-430.e1","DOI":"10.1053\/j.gastro.2018.04.009","article-title":"Outcomes of Early Liver Transplantation for Patients With Severe Alcoholic Hepatitis.","volume":"155","author":"B Lee","year":"2018","journal-title":"Gastroenterology."},{"key":"ref-100","doi-asserted-by":"publisher","first-page":"472-480.e5","DOI":"10.1053\/j.gastro.2019.04.012","article-title":"Model to Calculate Harms and Benefits of Early vs Delayed Liver Transplantation for Patients With Alcohol-Associated Hepatitis.","volume":"157","author":"B Lee","year":"2019","journal-title":"Gastroenterology."},{"key":"ref-101","doi-asserted-by":"publisher","first-page":"1477-87","DOI":"10.1002\/hep.30478","article-title":"Predicting Low Risk for Sustained Alcohol Use After Early Liver Transplant for Acute Alcoholic Hepatitis: The Sustained Alcohol Use Post-Liver Transplant Score.","volume":"69","author":"B Lee","year":"2019","journal-title":"Hepatology."}],"container-title":["F1000Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/f1000research.com\/articles\/9-97\/v1\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/9-97\/v1\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/9-97\/v1\/iparadigms","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T14:17:27Z","timestamp":1614349047000},"score":1,"resource":{"primary":{"URL":"https:\/\/f1000research.com\/articles\/9-97\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,10]]},"references-count":101,"URL":"https:\/\/doi.org\/10.12688\/f1000research.20394.1","relation":{"has-review":[{"id-type":"doi","id":"10.5256\/f1000research.22413.r59594","asserted-by":"subject"},{"id-type":"doi","id":"10.5256\/f1000research.22413.r59592","asserted-by":"subject"}]},"ISSN":["2046-1402"],"issn-type":[{"value":"2046-1402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,10]]},"assertion":[{"value":"Indexed","URL":"https:\/\/f1000research.com\/articles\/9-97\/v1#article-reports","order":0,"name":"referee-status","label":"Referee status","group":{"name":"current-referee-status","label":"Current Referee Status"}},{"value":"10.5256\/f1000research.22413.r59592, Suthat Liangpunsakul, Division of Gastroenterology and Hepatology, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA, 10 Feb 2020, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/9-97\/v1#referee-response-59592","order":0,"name":"referee-response-59592","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"10.5256\/f1000research.22413.r59594, Sandeep Singh Sidhu, Department of Gastroenterology, Dayanand Medical College and Hospital, Ludhiana, Punjab, India, 10 Feb 2020, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/9-97\/v1#referee-response-59594","order":1,"name":"referee-response-59594","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"Work by RB is supported by the National Institute on Alcohol Abuse and Alcoholism [1U01AA026978-01, 1U01AA026972-01, 1U01AA026264-01]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","order":2,"name":"grant-information","label":"Grant Information"},{"value":"This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.","order":0,"name":"copyright-info","label":"Copyright"}]}}